Overview hyperlipidemia. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Liver Adipose Tissue Aorta Endothelium, Vascular Kidney Carotid Arteries Macrophages Chromosomes, Human, Pair 1

Organisms15

Gynostemma Mice, Inbred C57BL Mice, Knockout Gadiformes Rats, Zucker Rats, Sprague-Dawley Angelica sinensis Tamarindus Mice, Transgenic Spirulina Rats, Wistar Mice, Obese Rats, Mutant Strains Rabbits Plants, Medicinal

Diseases51

Hyperlipidemia, Familial Combined Hyperlipidemias Hypertriglyceridemia Hyperlipoproteinemia Type IV Hypercholesterolemia Xanthomatosis Arteriosclerosis Obesity Hyperlipoproteinemia Type II Atherosclerosis Hyperlipoproteinemia Type III Diabetes Mellitus Hypertension Fatty Liver Insulin Resistance Disease Models, Animal Dyslipidemias Diabetes Mellitus, Type 2 Cardiovascular Diseases Hyperlipoproteinemias Body Weight Nephrotic Syndrome Hyperlipoproteinemia Type V Hyperglycemia Hyperlipoproteinemia Type I Diabetes Complications Coronary Disease Coronary Artery Disease Diabetes Mellitus, Experimental Metabolic Syndrome X Empty Sella Syndrome Stroke Glomerulosclerosis, Focal Segmental Intestinal Polyposis Proteinuria Metabolic Diseases Nephrosis Kidney Diseases Erectile Dysfunction Hyperinsulinism Lipodystrophy Rhabdomyolysis Genetic Predisposition to Disease Thrombosis Hyperhomocysteinemia Intracranial Arteriosclerosis Neoplasms Liver Diseases Myocardial Infarction Carotid Artery Diseases Disease Progression

Chemicals and Drugs99

Triglycerides Hypolipidemic Agents Lipids Cholesterol Cholesterol, LDL Lipoproteins Apolipoproteins E Apolipoproteins B Cholesterol, HDL Apolipoproteins C Apolipoprotein E2 Apolipoprotein C-III Lipoprotein Lipase Fenofibrate Lipoproteins, VLDL Anticholesteremic Agents Hydroxymethylglutaryl-CoA Reductase Inhibitors Apolipoproteins Lipoproteins, LDL Cholesterol, VLDL Receptors, LDL Dietary Fats Poloxamer Heptanoic Acids Blood Glucose Apolipoprotein A-I Cholesterol, Dietary Bezafibrate Epichlorohydrin Apolipoproteins A Simvastatin Insulin Pyrroles Apolipoprotein E3 Fatty Acids, Nonesterified Gemfibrozil Apolipoprotein B-48 Lipoproteins, IDL Pravastatin Chylomicrons Apolipoprotein A-II Lipase Upstream Stimulatory Factors Apolipoprotein B-100 Plant Extracts Apolipoprotein C-I Sterol Regulatory Element Binding Proteins Lovastatin Fatty Acids Cholesterol Ester Transfer Proteins Biological Markers Lipoproteins, HDL Azetidines Sterol O-Acyltransferase Hypoglycemic Agents Stearoyl-CoA Desaturase Sterol Regulatory Element Binding Protein 1 Clofibric Acid Cyclooctanes Resins, Synthetic Niacin PPAR alpha Dietary Sucrose Bile Acids and Salts Group IB Phospholipases A2 Lipoprotein(a)Fatty Acids, Monounsaturated Clofibrate Phytosterols RNA, Messenger Leptin Cholesterol Esters Hemoglobin A, Glycosylated Diacylglycerol O-Acyltransferase Carrier Proteins Anti-Obesity Agents Drugs, Chinese Herbal Soybean Proteins Antioxidants Cholestyramine Resin Adiponectin Immunosuppressive Agents HIV Protease Inhibitors Receptors, Lipoprotein Hydroxymethylglutaryl CoA Reductases Fat Emulsions, Intravenous Antigens, CD36 Antihypertensive Agents Glucose Resistin Phosphodiesterase 5 Inhibitors Fatty Acids, Omega-3 Phosphatidylcholine-Sterol O-Acyltransferase Streptozocin Apolipoprotein C-II Phospholipids Fluorobenzenes Receptors, Cytoplasmic and Nuclear Cyclosporine

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Risk Factors Obesity Diet, Atherogenic Disease Models, Animal Body Weight Phytotherapy Treatment Outcome Diabetes Mellitus, Experimental Retrospective Studies Prevalence Risk Assessment Pedigree Diet, Fat-Restricted Diet Therapy Body Mass Index Regression Analysis Organ Size Blood Pressure Clinical Trials as Topic Prospective Studies Follow-Up Studies Drug Therapy, Combination Apitherapy Models, Biological Cohort Studies Case-Control Studies Double-Blind Method Glucose Tolerance Test Incidence Kidney Transplantation Randomized Controlled Trials as Topic Severity of Illness Index Cross-Sectional Studies Logistic Models Reference Values

Psychiatry and Psychology4

Fasting Erectile Dysfunction Smoking Life Style

Phenomena and Processes33

Lipid Metabolism Obesity Diet, Atherogenic Insulin Resistance Postprandial Period Body Weight Phenotype Diet, High-Fat Diet Time Factors Lipolysis Diet, Fat-Restricted Gene Expression Regulation Particle Size Fasting Body Mass Index Organ Size Oxidative Stress Genetic Linkage Signal Transduction Blood Pressure Alleles Oxidation-Reduction Polymorphism, Genetic Genetic Predisposition to Disease Genotype Lipogenesis Eating Gene Expression Polymorphism, Single Nucleotide Chromosomes, Human, Pair 1 Intestinal Absorption Dose-Response Relationship, Drug

Technology, Industry, Agriculture6

Dietary Fats Poloxamer Resins, Synthetic Dietary Sucrose Soybean Proteins Cholestyramine Resin

Humanities1

History, 20th Century

Information Science2

Prevalence Incidence

Health Care24

Risk Factors Treatment Outcome Age Factors Retrospective Studies Prevalence Risk Assessment Comorbidity Sex Factors Body Mass Index Regression Analysis Practice Guidelines as Topic Family Health Clinical Trials as Topic Prospective Studies Follow-Up Studies Cohort Studies Case-Control Studies Double-Blind Method Incidence Randomized Controlled Trials as Topic Disease Management Severity of Illness Index Cross-Sectional Studies Logistic Models

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care Geographicals

Hyperlipidemia, Familial Combined Hyperlipidemias Triglycerides Hypolipidemic Agents Lipids Cholesterol Hypertriglyceridemia Cholesterol, LDL Hyperlipoproteinemia Type IV Lipoproteins Lipid Metabolism Apolipoproteins E Hypercholesterolemia Apolipoproteins B Cholesterol, HDL Apolipoproteins C Apolipoprotein E2 Apolipoprotein C-III Lipoprotein Lipase Fenofibrate Xanthomatosis Lipoproteins, VLDL Risk Factors Anticholesteremic Agents Arteriosclerosis Hydroxymethylglutaryl-CoA Reductase Inhibitors Liver Apolipoproteins Lipoproteins, LDL Cholesterol, VLDL Gynostemma Obesity Hyperlipoproteinemia Type II Receptors, LDL Dietary Fats Atherosclerosis Hyperlipoproteinemia Type III Poloxamer Diabetes Mellitus Heptanoic Acids Hypertension Diet, Atherogenic Blood Glucose Apolipoprotein A-I Cholesterol, Dietary Mice, Inbred C57BL Fatty Liver Insulin Resistance Postprandial Period Disease Models, Animal Bezafibrate Epichlorohydrin Dyslipidemias Diabetes Mellitus, Type 2 Cardiovascular Diseases Apolipoproteins A Hyperlipoproteinemias Simvastatin Body Weight Insulin Pyrroles Nephrotic Syndrome Hyperlipoproteinemia Type V Mice, Knockout Phytotherapy Apolipoprotein E3 Fatty Acids, Nonesterified Gemfibrozil Gadiformes Treatment Outcome Apolipoprotein B-48 Lipoproteins, IDL Hyperglycemia Pravastatin Phenotype Chylomicrons Diet, High-Fat Diet Apolipoprotein A-II Lipase Upstream Stimulatory Factors Time Factors Apolipoprotein B-100 Hyperlipoproteinemia Type I Plant Extracts Diabetes Complications Coronary Disease United States Apolipoprotein C-I Adipose Tissue Sterol Regulatory Element Binding Proteins Lovastatin Fatty Acids Age Factors Coronary Artery Disease Cholesterol Ester Transfer Proteins Diabetes Mellitus, Experimental Retrospective Studies Biological Markers Lipolysis

No FAQ available that match "overview hyperlipidemia"